Richard G. Vincent is CFO at Oncternal Therapeutics, Inc. (ONCT). They have made 3 open-market trades across 1 company since 2022, most recently 2024-01-03.
CIK 0001269341
3 open-market purchases totalling $38K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ONCT | 140,922 | $74K |
Shares reported on the most recent Form 4, priced at the 2024-01-05 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.